Company profileSME (from the award notice)
ACA Müller ADAG Pharma AG
- Legal form
- AG
- Seat
- Gottmadingen, Germany
Based on the notices and sources Inteliwert covers; not a complete record. Last checked 1 October 2024.
Identifiers
As the covered sources state them.
- Register entry
- HRB 541570
Track record in public tenders
Awards in the covered notices over the last 36 months, per CPV division.
| CPV division | Awards | Award value (excl. VAT) | Buyers | Repeat buyers | First award | Last award |
|---|---|---|---|---|---|---|
| 33 Medical equipments, pharmaceuticals and personal care products | 2 | — | 1 | 1 | 1 September 2024 | 1 October 2024 |
Awards
- Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Faricimab, ATC S01LA09 für die Zeit 01.10.2024 - 30.09.2026Buyer: DAK-Gesundheit · Awarded: 1 October 2024 · CPV 33600000
- Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Tacrolimus, ATC L04AD02 für die Zeit 01.09.2024 - 31.08.2025 (zzgl. Verlängerungsoption 1x12 Monate)Buyer: DAK-Gesundheit · Awarded: 1 September 2024 · CPV 33600000
Certifications and prequalification
No certification or prequalification found in the covered sources.
A certification missing here is unknown, not absent.
Website and LinkedIn
Not found in the indexed notices.
Open tenders that might fit
Possible match based on public information
Companies Inteliwert knows from its sources, not the whole market. Inteliwert does not judge eligibility, fit or chances.
-
OpenTenderSME (from the award notice)
Open-House-Rabattverträge 2026-16 (aut idem)
Reasons
- Won a contract in CPV group 336 (2024-10-01) Evidence · checked 7 Nov 2026
- Seat in the same country as the place of performance Evidence · checked 7 Nov 2026
- 2 awards in this field in 36 months, from 1 buyer Evidence · checked 7 Nov 2026
Last checked 7 Nov 2026, 06:30 (UTC+01:00)Official notice -
OpenTenderSME (from the award notice)New to public tenders
Abschluss nicht-exklusiver Rabattvereinbarungen nach § 130 a Abs. 8 SGB V ab dem 01.11.2026
Reasons
- Won a contract in CPV group 336 (2024-10-01) Evidence · checked 6 Nov 2026
- Seat in the same country as the place of performance Evidence · checked 6 Nov 2026
- 1 award in this field in 36 months, from 1 buyer Evidence · checked 6 Nov 2026
Last checked 6 Nov 2026, 22:30 (UTC+01:00)Official notice -
OpenTenderSME (from the award notice)New to public tenders
Arzneimittelverträge mit Beitrittsoption
Reasons
- Won a contract in CPV group 336 (2024-10-01) Evidence · checked 7 Nov 2026
- Seat in the same country as the place of performance Evidence · checked 7 Nov 2026
- 1 award in this field in 36 months, from 1 buyer Evidence · checked 7 Nov 2026
Last checked 7 Nov 2026, 02:30 (UTC+01:00)Official notice -
OpenTenderSME (from the award notice)New to public tenders
Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Natalizumab (ATC-Code nach WHO: L04AG03)
Reasons
- Won a contract in CPV group 336 (2024-10-01) Evidence · checked 7 Nov 2026
- Seat in the same country as the place of performance Evidence · checked 7 Nov 2026
- 1 award in this field in 36 months, from 1 buyer Evidence · checked 7 Nov 2026
Last checked 6 Nov 2026, 23:30 (UTC+01:00)Official notice -
OpenTenderSME (from the award notice)New to public tenders
Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Apixaban (ATC-Code nach WHO: B01AF02)
Reasons
- Won a contract in CPV group 336 (2024-10-01) Evidence · checked 7 Nov 2026
- Seat in the same country as the place of performance Evidence · checked 7 Nov 2026
- 1 award in this field in 36 months, from 1 buyer Evidence · checked 7 Nov 2026
Last checked 6 Nov 2026, 23:30 (UTC+01:00)Official notice -
OpenTenderSME (from the award notice)New to public tenders
Open-House-Verträge 2026 - Aflibercept (Kopie)
Reasons
- Won a contract in CPV group 336 (2024-10-01) Evidence · checked 7 Nov 2026
- 1 award in this field in 36 months, from 1 buyer Evidence · checked 7 Nov 2026
Last checked 7 Nov 2026, 04:30 (UTC+01:00)Official notice -
OpenTenderSME (from the award notice)New to public tenders
Testkits zum molekularbiologischen Nachweis des Virus der Afrikanischen Schweinepest, der Europäischen Schweinepest sowie der Blauzungenkrankheit mittels real-time PCR
Reasons
- Won a contract in CPV group 336 (2024-10-01) Evidence · checked 7 Nov 2026
- 1 award in this field in 36 months, from 1 buyer Evidence · checked 7 Nov 2026
Last checked 7 Nov 2026, 04:30 (UTC+01:00)Official notice
Is this your company?
Send corrections, or ask us to remove the profile, to hello@inteliwert.com. You can also ask that the company never be tagged on LinkedIn.
About this profile
Each fact on this page shows its source: a public notice, an open-data register (GLEIF, Wikidata) or the company’s own website. Inteliwert does not rate companies and does not judge eligibility, fit or chances.
Based on the notices and sources Inteliwert covers; not a complete record.
Last checked 1 October 2024.